Cord Blood America, Inc. (CBAI):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Cord Blood America, Inc. (CBAI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82573FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Cord Blood America, Inc. (CBAI) is a stem cell storage company. The company provides private cord blood stem cell preservation services. It offers processing and storage services for use by other cord blood banking brands. CBAI provides customized cord blood processing solutions utilizing a non automated processing technique. It partners with AmeriHealth, AmeriHealth Administrators, Asuris Northwest Health, Blue Cross Blue Shield of Kansas, Blue Cross Blue Shield of Northeastern Pennsylvania, and Highmark Inc. CBAI is headquartered in Las Vegas, Nevada, the US.

Cord Blood America, Inc. Key Recent Developments

Nov 14, 2013: Cord Blood America Announces 2013 Third Quarter Financial Results
May 15, 2013: Cord Blood America Reports Revenue Of $1.5m In Q1 2013
Apr 01, 2013: Cord Blood America Reports Revenue Of $6m In 2012

This comprehensive SWOT profile of Cord Blood America, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cord Blood America, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cord Blood America, Inc. – Key Information
Cord Blood America, Inc. – Overview
Cord Blood America, Inc. – Key Employees
Cord Blood America, Inc. – Key Employee Biographies
Cord Blood America, Inc. – Key Operational Heads
Cord Blood America, Inc. – Major Products and Services
Cord Blood America, Inc. – History
Cord Blood America, Inc. – Company Statement
Cord Blood America, Inc. – Locations And Subsidiaries
Cord Blood America, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cord Blood America, Inc. – Business Description
Cord Blood America, Inc. – Corporate Strategy
Cord Blood America, Inc. – SWOT Analysis
SWOT Analysis – Overview
Cord Blood America, Inc. – Strengths
Cord Blood America, Inc. – Weaknesses
Cord Blood America, Inc. – Opportunities
Cord Blood America, Inc. – Threats
Cord Blood America, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Cord Blood America, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cord Blood America, Inc., Key Information
Cord Blood America, Inc., Key Ratios
Cord Blood America, Inc., Share Data
Cord Blood America, Inc., Major Products and Services
Cord Blood America, Inc., History
Cord Blood America, Inc., Key Employees
Cord Blood America, Inc., Key Employee Biographies
Cord Blood America, Inc., Key Operational Heads
Cord Blood America, Inc., Other Locations
Cord Blood America, Inc., Subsidiaries
Cord Blood America, Inc., Key Manufacturing facilities
Cord Blood America, Inc., Key Competitors
Cord Blood America, Inc., SWOT Analysis
Cord Blood America, Inc., Ratios based on current share price
Cord Blood America, Inc., Annual Ratios
Cord Blood America, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Cord Blood America, Inc., Performance Chart
Cord Blood America, Inc., Ratio Charts

★海外企業調査レポート[Cord Blood America, Inc. (CBAI):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adaptive Biotechnologies Corp:企業のM&A・提携動向(医療分野)
    Summary Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories to conduct re …
  • Intelligent Living Technologies Inc. (OXDG):企業の財務及び戦略的SWOT分析
    Summary Intelligent Living Technologies Inc. (ILTI) is a technology service provider that offers design, supply, installation, upgrading, and servicing control and automation systems to provide energy efficient solutions for clients. The company’s solutions include energy use monitoring and conserva …
  • Osteologix, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Osteologix, Inc. Mergers and Ac …
  • Arno Therapeutics, Inc. (ARNI):企業のM&A・提携動向(医療機器分野)
    Summary Arno Therapeutics, Inc. (Arno Therapeutics) develops products for the treatment of various types of cancer. The company's product pipeline comprises Onapristone, indicated for breast and endometrial cancer; AR-42, being evaluated to treat hematological malignancies and solid tumors; and AR-1 …
  • Mitsubishi Electric Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Fichtner GmbH & Co. KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Boule Diagnostics AB (BOUL):企業概要、財務及び戦略的SWOT分析
    Summary Boule Diagnostics AB (Boule) is a healthcare service provider. The company develops, manufactures and sells systems and consumer products for complete blood counts to non-institutional healthcare. It concentrates on small and midsize hospitals, clinics and laboratories in non-institutional h …
  • The Travelers Companies, Inc.:企業の戦略・SWOT・財務分析
    SummaryThe Travelers Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Jai Balaji Industries Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Jai Balaji Industries Ltd. Merg …
  • Mustang Survival Corp.(航空・防衛):企業概要、SWOT分析
    Summary Strategic Defence Intelligence's "Mustang Survival Corp.: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, bu …
  • Veresen Inc. (VSN):企業のM&A・提携動向(エネルギー分野)
    Summary Veresen Inc. (Veresen) is a diversified energy infrastructure company that provides services in the areas of pipelines, midstream and power. The company’s pipeline business comprises of interests in two pipeline systems which include the Alliance Pipeline and Alberta Ethane Gathering System. …
  • Rubicon Genomics Inc:企業のM&A・提携動向(医療機器分野)
    Summary Rubicon Genomics Inc (Rubicon) is a biotechnology company that develops and commercializes pre-analytical processes to improve the performance and capabilities of analytical platforms for research and clinical testing. The company’s core competencies include enzymology, nucleic acid chemistr …
  • The State Trading Corporation of India Limited (STCINDIA):企業の財務及び戦略的SWOT分析
    Summary The State Trading Corporation of India Limited (STC) is an international trading company that offers agro commodities, hydrocarbons, metals, minerals, ores, fertilizers and petrochemicals. The company’s agro commodities include grains, pulses, edible oil, oil seeds and extractions, coarse gr …
  • MEI Pharma Inc (MEIP):企業のM&A・提携動向(医療分野)
    Summary MEI Pharma, Inc. (MEI), formerly Marshall Edwards Inc., is an oncology company that focuses on the development of drugs for the treatment of cancer. The company’s drug candidates include pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia (AML), …
  • Berkeley Resources Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Berkeley Resources Ltd. Mergers …
  • KapStone Paper and Packaging Corporation:戦略・SWOT・企業財務分析
    KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report Summary KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • The Bancorp, Inc.:企業の戦略・SWOT・財務分析
    SummaryThe Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • OncoTherapy Science Inc (4564):企業のM&A・提携動向(医療機器分野)
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs. The company offers products under clinical development and anti-cancer medicines. It provides technology platforms that include laser micro-beam microdissection, cDNA microarray and i …
  • Neuravi Limited:企業のM&A・提携動向(医療機器分野)
    Summary Neuravi Limited (Neuravi) is a medical device company that develops and commercializes endovascular devices. The company's embotrap revascularization device is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embotrap revascularization device i …
  • Get Nice Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Get Nice Holdings Limited Merge …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆